P2.07-09 Stage 3 NSCLC Patients Progressing After Concurrent Chemo-Radiotherapy and Durvalumab- is There a Role for Another IO? von Shentzer Kutiel, T., Moskovitz, M., Shamai, S., Waissengrin, B., Urban, D., Daher, S., Sorotzky, H., Wollner, M., Zer, A., Reinhorn, D., Rotem, O., Alon, A., Bar, J.

Volltext

41P Progression after chemo-IO and durvalumab in stage III non-small cell lung cancer (NSCLC): What should be the next line? Real-world study von Shentzer Kutiel, T., Shamai, S., Waissengrin, B., Urban, D., Daher, S., Sorotzky, H., Wollner, M., Zer, A., Bar, J., Moskovitz, M.

Volltext